Eloxx Pharmaceuticals, Inc. (ELOX)
OTCMKTS: ELOX · Delayed Price · USD
0.900
+0.050 (5.88%)
Mar 27, 2024, 3:37 PM EDT - Market closed
Eloxx Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2017 | 2016 | 2015 | 2014 | 2013 - 1997 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.08 | 0.1 | Upgrade
|
Revenue Growth (YoY) | - | - | - | - | - | - | - | 0% | -25.00% | - | Upgrade
|
Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.08 | 0.1 | Upgrade
|
Selling, General & Admin | 10.69 | 20.45 | 14.85 | 24.21 | 26.48 | 2.7 | 1.46 | 1.41 | 2.74 | 2.61 | Upgrade
|
Research & Development | 23.73 | 45.57 | 14.59 | 26.35 | 20.49 | 16.4 | 0.73 | 2.18 | 4.57 | 3.34 | Upgrade
|
Other Operating Expenses | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Operating Expenses | 34.42 | 66.02 | 29.44 | 50.56 | 46.97 | 19.1 | 2.14 | 3.79 | 7.74 | 7.02 | Upgrade
|
Operating Income | -34.42 | -66.02 | -33.46 | -50.56 | -47.57 | -20.39 | -4.59 | -11.19 | -18.08 | -9.15 | Upgrade
|
Interest Income | 0.27 | 0.01 | 0.34 | 1.07 | 0.6 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Interest Expense | 1.95 | 1.26 | 1.41 | 1.62 | 0.01 | 0.04 | 0.27 | 0 | 0 | 0.08 | Upgrade
|
Other Expense / Income | -2.06 | -1.8 | -1.36 | -1.84 | 0.09 | 0.74 | 1.98 | -2.25 | -0.02 | -0.08 | Upgrade
|
Pretax Income | -36.07 | -66.73 | -34.58 | -50.87 | -47.06 | -21.21 | -6.84 | -8.95 | -18.06 | -9.23 | Upgrade
|
Income Tax | 2.03 | 1.26 | 1.41 | 1.62 | 0.12 | 0.04 | -1.04 | -0.68 | 0 | 0.08 | Upgrade
|
Net Income | -36.07 | -66.73 | -34.58 | -50.87 | -47.19 | -21.21 | -5.8 | -8.27 | -18.06 | -9.23 | Upgrade
|
Shares Outstanding (Basic) | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Outstanding (Diluted) | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Change | 23.85% | 74.36% | 5.42% | 17.35% | 551.81% | 328.64% | 14.25% | 40.96% | 163.27% | 301.00% | Upgrade
|
EPS (Basic) | -16.65 | -38.15 | -34.47 | -53.46 | -58.19 | -170.52 | -199.71 | -325.47 | -1002.37 | -1347.73 | Upgrade
|
EPS (Diluted) | -16.65 | -38.15 | -34.47 | -53.46 | -58.19 | -170.52 | -199.71 | -325.47 | -1002.37 | -1347.73 | Upgrade
|
Free Cash Flow | -31.91 | -35.09 | -28.17 | -39.43 | -31.6 | -16.17 | -1.93 | -3.68 | -7.6 | -5.5 | Upgrade
|
Free Cash Flow Per Share | -14.73 | -20.06 | -28.08 | -41.44 | -38.97 | -129.99 | -66.41 | -144.72 | -421.97 | -802.90 | Upgrade
|
Gross Margin | - | - | - | - | - | - | - | 100.00% | 100.00% | 100.00% | Upgrade
|
Operating Margin | - | - | - | - | - | - | - | -14926.64% | -24102.31% | -9147.80% | Upgrade
|
Profit Margin | - | - | - | - | - | - | - | -11023.91% | -24085.05% | -9225.23% | Upgrade
|
Free Cash Flow Margin | - | - | - | - | - | - | - | -4901.62% | -10139.04% | -5495.86% | Upgrade
|
EBITDA | -33.37 | -65.05 | -28.53 | -48.92 | -46.15 | -19.69 | -3.52 | -3.62 | -7.49 | -6.57 | Upgrade
|
EBITDA Margin | - | - | - | - | - | - | - | -4827.52% | -9982.48% | -6572.38% | Upgrade
|
Depreciation & Amortization | 0.7 | 0.96 | 0.57 | 0.56 | 0.22 | 0.04 | 0.04 | 0.09 | 0.18 | 0.35 | Upgrade
|
EBIT | -34.07 | -66.01 | -29.1 | -49.48 | -46.37 | -19.73 | -3.56 | -3.71 | -7.66 | -6.92 | Upgrade
|
EBIT Margin | - | - | - | - | - | - | - | -4952.04% | -10218.58% | -6922.04% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.